Are you Dr. Bajaj?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 26 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
# A-53
Cleveland, OH 44195Phone+1 216-445-0682Fax+1 216-445-1656
Summary
- Dr. Harpreet Bajaj, MD is an endocrinologist in Cleveland, Ohio.
Education & Training
Hennepin HealthcareResidency, Internal Medicine, 2004 - 2007
Maulana Azad Medical CollegeClass of 2001
Clinical Trials
- Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria Start of enrollment: 2013 Oct 01
- Randomized Trial Comparing Colesevelam vs. Ezetimibe Start of enrollment: 2016 Jan 11
- The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians Start of enrollment: 2018 Oct 02
Publications & Presentations
PubMed
- 94 citationsRenal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial.Meg Jardine, Zien Zhou, Kenneth W. Mahaffey, Megumi Oshima, Rajiv Agarwal
Journal of the American Society of Nephrology. 2020-05-01 - 32 citationsSGLT2 inhibitors and incretin agents: Associations with alanine aminotransferase activity in type 2 diabetesHarpreet S. Bajaj, Ruth E. Brown, L. Bhullar, N. Sohi, S. Kalra
Diabetes & Metabolism. 2018-12-01 - 63 citationsSwitching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized...Harpreet S. Bajaj, Richard M. Bergenstal, Andreas Christoffersen, Melanie J. Davies, Amoolya Gowda
Diabetes Care. 2021-07-01
Press Mentions
Novo Nordisk Tees up Phase 3 Trial for Once-Weekly InsulinSeptember 24th, 2020- Switching to Investigational Once-Weekly Insulin Icodec from Other Basal Insulins Demonstrated to Be Efficacious and Well-Tolerated for People with Type 2 Diabetes in Phase 2 TrialSeptember 22nd, 2020
Type 2 Diabetes May Be Preventable, but Why Isn't Type 1?November 14th, 2019- Join now to see all
